EvolveImmune Therapeutics
Sonali D. is currently serving as the Biotherapeutics Lead at EvolveImmune Therapeutics. Prior to this role, Sonali held positions as a Senior Scientist and Consultant at the same company. Sonali has valuable experience as a Postdoctoral Research Fellow at both Northwestern University and The City University of New York, where Sonali worked on projects related to viral entry mechanisms and Excitation-Contraction coupling machinery. Sonali D. completed their Ph.D. in Biotechnology and Structural Biology from Indian Institute of Technology, Roorkee, and holds a Masters in Pharmacoinformatics from National Institute of Pharmaceutical Education and Research. Sonali also obtained their Bachelors in Pharmacy from Delhi Institute of Pharmaceutical Education and Research.
EvolveImmune Therapeutics
2 followers
EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.